About: SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
Latest price: $0.02 (+35.71%)
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
SABSW NASDAQ SAB Biotherapeutics Inc
SAB Biotherapeutics Inc share price
SABSW price activity
Last Price
$0.020
Change (24hr)
0.01 USD (35.71%)
Volume
47.59K
Volume (4w avg)
-
Open
$0.02
Day Range
$0.02 - $0.04
Previous Close
$0.01
Last Trade
11 Sep, 8:06 pm GMT+0
Delayed
11 Sep, 8:06 pm GMT+0
SABSW price performance
Delayed
11 Sep, 8:06 pm GMT+0
SABSW Market Signals